Drug recall · May 29, 2013
Levoxyl recall
Why: Subpotent Drug: The products were below specification for potency at the expiry stability point.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Levoxyl (levothyroxine sodium) tablets, USP, 125 mcg, packaged in a) 100-count bottles (NDC 60793-856-01) and b) 1000-count bottles (NDC 60793-856-10), Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc., Bristol, TN 37620
- Lots / codes
Lot # a) 64333, Exp. 5/13; 64937, Exp. 6/13; 65629, Exp. 7/13; and 66296, Exp. 9/13; b) 64931, Exp. 5/13 and 65766, Exp. 7/13
- Quantity
- 103,796 bottles
- Company
- King Legacy, a wholly owned subsidiary of Pfizer, Bristol, TN
- Distribution
- Nationwide and Puerto Rico
- Initiated
- April 30, 2013 · Voluntary: Firm initiated
- Classified
- May 20, 2013
- Reported
- May 29, 2013
- Ended
- June 30, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Levoxyl
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.